These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Focus on HDL as a therapeutic target for CAD risk reduction. Davidson MH Am J Cardiol; 2009 Nov; 104(10 Suppl):1E-2E. PubMed ID: 19895937 [No Abstract] [Full Text] [Related]
4. Statins. Cholesterol treatment and beyond. Mayo Clin Health Lett; 2004 Nov; 22(11):1-3. PubMed ID: 15619748 [No Abstract] [Full Text] [Related]
5. Lipid management with statins. The lower the better? Laufs U; Liao JK; Böhm M Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235 [TBL] [Abstract][Full Text] [Related]
6. Implications from the Air Force/Texas Coronary Atherosclerosis Prevention Study for the Adult Treatment Panel III guidelines. Clearfield M; Downs JR; Lee M; Langendorfer A; McConathy W; Gotto AM Am J Cardiol; 2005 Dec; 96(12):1674-80. PubMed ID: 16360356 [TBL] [Abstract][Full Text] [Related]
7. Cholesteryl ester transfer protein TaqIB polymorphism in the cholesterol and recurrent events study. Marian AJ Curr Atheroscler Rep; 2005 May; 7(3):178-9. PubMed ID: 15811250 [No Abstract] [Full Text] [Related]
8. [Can higher level of HDL cholesterol augment cardiovascular disease prevention? The combination statins-nicotinic acid increases the level of HDL and reduces the level of LDL cholesterol]. Carlson LA Lakartidningen; 2006 Oct 25-31; 103(43):3283-5. PubMed ID: 17117660 [No Abstract] [Full Text] [Related]
9. Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Gotto AM; Whitney E; Stein EA; Shapiro DR; Clearfield M; Weis S; Jou JY; Langendörfer A; Beere PA; Watson DJ; Downs JR; de Cani JS Eur Heart J; 2000 Oct; 21(19):1627-33. PubMed ID: 10988016 [TBL] [Abstract][Full Text] [Related]
11. [Hyperlipidemia: decreasing lipid values and effects of statins]. Mathes P Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762 [No Abstract] [Full Text] [Related]
12. The case for medical treatment in chronic stable coronary artery disease. Nash DT Arch Intern Med; 2005 Dec 12-26; 165(22):2587-9, discussion 2593-4. PubMed ID: 16344414 [No Abstract] [Full Text] [Related]
13. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects. Agrawal AR; Tandon M; Sharma PL Int J Clin Pract; 2007 Nov; 61(11):1812-8. PubMed ID: 17935545 [TBL] [Abstract][Full Text] [Related]
14. Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy. Rosenson RS Am Heart J; 2006 Mar; 151(3):556-63. PubMed ID: 16504615 [TBL] [Abstract][Full Text] [Related]
15. [Cholesterol: how and when to treat it?]. Masana Marín L Med Clin (Barc); 1985 Oct; 85(10):423-5. PubMed ID: 4079497 [No Abstract] [Full Text] [Related]
17. Lipid-lowering medications: what the new guidelines and data mean to women. Schwartz JB J Gend Specif Med; 2001; 4(2):9-13. PubMed ID: 11480105 [No Abstract] [Full Text] [Related]
18. Statins are magic when you gotta have heart. Comarow A US News World Rep; 2001 Apr; 130(15):54-5. PubMed ID: 11330169 [No Abstract] [Full Text] [Related]
20. Can cholesterol lowering be too aggressive? Johns Hopkins Med Lett Health After 50; 1999 Aug; 11(6):3. PubMed ID: 10453711 [No Abstract] [Full Text] [Related] [Next] [New Search]